IL21 and B-cell chronic lymphocytic leukemia: Taken together, the two AKT inhibitors with different modes of action produced similar effects on CLL-cell mitosis induced by CD154 + IL-21, both inhibiting proliferation in the same six patient samples but not inhibiting such proliferation in the two other samples.